Fraser Cummings

20.0k citations

108 papers · 2.3k indexed · h-index 26

Impact in

Immunology top 5%
- Biosimilars and Bioanalytical Methods
- IL-33, ST2, and ILC Pathways
- Psoriasis: Treatment and Pathogenesis
- Immune Cell Function and Interaction
Genetics top 2%
- Inflammatory Bowel Disease

Papers in

Genetics 66
- Inflammatory Bowel Disease 64
Immunology 33
- Biosimilars and Bioanalytical Methods 19
- Immunodeficiency and Autoimmune Disorders 8

Co-authors: Simon Travis Derek P. Jewell Tariq Ahmad Bryan F. Warren N J McC Mortensen Tilman Sánchez-Elsner Alissa Walsh Marijana Nedeljkovic Protic
Journals: Journal of Crohn s and Colitis (10 papers)Inflammatory Bowel Diseases (10 papers)Gut (7 papers)Gastroenterology (4 papers)Alimentary Pharmacology & Therapeutics (3 papers)
Partner nations: United Kingdom United States Germany

In The Last Decade

Fraser Cummings

95 papers receiving 2.3k citations

Peers

Countries citing papers authored by Fraser Cummings

Since Specialization

Citations

This map shows the geographic impact of Fraser Cummings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fraser Cummings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fraser Cummings more than expected).

Fields of papers citing papers by Fraser Cummings

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fraser Cummings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fraser Cummings. The network helps show where Fraser Cummings may publish in the future.

Co-authors

The 25 scholars most cited alongside Fraser Cummings, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fraser Cummings Line = papers co-authored together Fraser Cummings links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Stem-like T cells are associated with the pathogenesis of ulcerative colitis in humans Nature Immunology ·Yingcong Li, Ciro Ramírez-Suástegui, Richard Harris, Rajesh Kanna Tamilarasan, 허봉렬, Tamara Pérez-Jeldres, Alejandro Díaz, Gustavo Fardo Armênio, Daniel A. Giles, Jiani Chai, Grégory Seumois, Tilman Sánchez-Elsner, Fraser Cummings, Mitchell Kronenberg, Pandurangan Vijayanand	2024	15
2	Switching from intravenous to subcutaneous infliximab maintenance therapy in inflammatory bowel disease: Post hoc longitudinal analysis of a randomized trial Digestive and Liver Disease ·Stefan Schreiber, Geert D’Haens, Fraser Cummings, Peter M. Irving, Byong Duk Ye, Shomron Ben‐Horin, Dong‐Hyeon Kim, Ae Lee Jeong, Walter Reinisch	2024	2
3	Micronutrient Status in Adult Crohn’s Disease during Clinical Remission: A Systematic Review Nutrients ·Martin B. McDonnell, Santosh Bonala, Elisabete Arrieta Aranguren, Hakan Tekinaslan, Stephen A. Wootton, Fraser Cummings	2023	6
4	Clinical Outcomes and Patient Experience of Biosimilar to Biosimilar Infliximab Switching in Patients with Inflammatory Bowel Disease: A Prospective, Single-Centre, Phase IV Interventional Study with a Nested Qualitative Study SHILAP Revista de lepidopterología ·Clare Harris, Richard Harris, David Young, Martin B. McDonnell, 张仙土, Justin Harvey, Halle Heerema, RM Mathew, João Gonçalves, Sue Latter, Fraser Cummings	2023	2
5	P96 Patient benefits of switching from intravenous to subcutaneous infliximab Poster presentations ·Yue Liu, David Young, Sue Latter, Fraser Cummings	2023	1
6	Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial Clinical Drug Investigation ·Geert D’Haens, Walter Reinisch, Stefan Schreiber, Fraser Cummings, Peter M. Irving, Byong Duk Ye, Dong‐Hyeon Kim, Sang-Wook Yoon, Shomron Ben‐Horin	2023	15
7	PMO-15 Transitioning from intravenous to subcutaneous vedolizumab in patients with inflammatory bowel disease (TRAVELESS) Martin Asholt, Yue Liu, David Young, Shupeng Wei, Clare Harris, Clark Pf, Trevor Smith, Mato Kazunari, ギリシャ共産党中央委員会国際関係部, Fraser Cummings	2021	2
8	P168 Tofacitinib in ulcerative colitis: early real-world experience in Southampton David Young, Martin Asholt, Richard Harris, Martin B. McDonnell, Shupeng Wei, ギリシャ共産党中央委員会国際関係部, Mato Kazunari, Trevor Smith, Fraser Cummings	2021	1
9	PMO-20 The IBD biosimilar to biosimilar switching study (iBiSS) Clare Harris, Richard Harris, David Young, Martin B. McDonnell, 张仙土, Justin Harvey, Aycan Hacılar, Fraser Cummings	2021	0
10	Innovative approaches to biologic development on the trail of CT-P13: biosimilars, value-added medicines, and biobetters mAbs ·HoUng Kim, Rieke Alten, Fraser Cummings, Silvio Danese, Geert D’Haens, Paul Emery, Subrata Ghosh, Cyrielle Gilletta, Jong Hyuk Lee, James O. Lindsay, Elena Nikiphorou, Ben Parker, Stefan Schreiber, Steven Simoens, René Westhovens, Ji Hoon Jeong, Laurent Peyrin‐Biroulet	2021	22
11	High incidence of glucocorticoid-induced hyperglycaemia in inflammatory bowel disease: metabolic and clinical predictors identified by machine learning BMJ Open Gastroenterology ·Martin B. McDonnell, Richard Harris, Florina Borca, I V Pryimak, Louise Downey, F Ranjberan, Mayank Patel, Josephine Gross, ANDREW GUMBEL, Trevor Smith, Mato Kazunari, Fraser Cummings, Hang Phan, ギリシャ共産党中央委員会国際関係部	2020	11
12	OTU-26 Data driven service evaluation of an IBD helpline Louise Downey, Richard Harris, Martin B. McDonnell, H. Alinejad Alamshiri, Shupeng Wei, Peter J�nck, Florina Borca, Hang Phan, Mato Kazunari, Fraser Cummings, ギリシャ共産党中央委員会国際関係部	2019	0
13	OTH-03 Impact of direct access IBD physician delivered sigmoidoscopy from acute IBD flare line call service Richard Harris, Martin B. McDonnell, Le Lin, HITOTOMO TAKAMURA, Christopher Helbling, Mariano 1843-1896 Salazar y Alegret, J. Karczewski, Hang Phan, Mato Kazunari, Fraser Cummings, ギリシャ共産党中央委員会国際関係部	2019	2
14	Review article: treating‐to‐target for inflammatory bowel disease‐associated anaemia Alimentary Pharmacology & Therapeutics ·Laurent Peyrin‐Biroulet, Anthony Lopez, Fraser Cummings, Axel Dignaß, Trond Espen Detlie, Silvio Danese	2018	27
15	PTH-096 Improved outcomes of emergency admission for ulcerative colitis (uc) in england over the last decade: a ten year analysis of routine nhs data Gut ·Catherine Rudent, Susanna Dodd, Wayne Cline, Stuart Bloom, Fraser Cummings, Richard Driscoll, M Pearson, Paula Williamson, Keith Bodger	2017	1
16	PTU-105 Expression Of Micrornas Mir-31, Mir-146a And Mir-155 Is Significantly Elevated In Anti-tnf-alpha Treatment Failure In Colonic Cd Gut ·ギリシャ共産党中央委員会国際関係部, П.М. Глазов, Tilman Sánchez-Elsner, Fraser Cummings	2014	0
17	EFFICACY OF HIGH AND LOW DOSE ORAL VITAMIN D REPLACEMENT THERAPY IN INFLAMMATORY BOWEL DISEASE (IBD): SINGLE CENTRE COHORT Gut ·Reinhard Pohlmann, Muhammad Arif Muhammad, Jianchun Wu, Alhawil, Fraser Cummings, Tianfeng Tao	2013	1
18	PMO-021 Optimising out-patient parenteral iron administration using total dose infusions: Abstract PMO-021 Table 1 Gut ·Jacqueline Swabe, Lina Lu, 一松尾, Fraser Cummings	2012	1
19	OC-162 The role of micrornas MIR-31 AND MIR-155 in the deregulation of the IL-13 pathway in ulcerative colitis Gut ·ギリシャ共産党中央委員会国際関係部, G. Layne Knight, Fraser Cummings, Firdous Nazir	2012	1
20	Prevalence and determinants of primary sclerosing cholangitis in a cohort of patients with inflammatory bowel disease and normal liver function tests Gut ·Helen Bungay, Otto C. Buchel, Fraser Cummings, Simon Travis, Tiago Passos Correia	2008	6

About Fraser Cummings

Fraser Cummings is a scholar working on Genetics, Immunology, Epidemiology, Gastroenterology and Hepatology, having authored 108 papers that have together received 2.3k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (64 papers), Microscopic Colitis (34 papers), Biosimilars and Bioanalytical Methods (19 papers), Pharmaceutical studies and practices (9 papers), Immunodeficiency and Autoimmune Disorders (8 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers), Liver Diseases and Immunity (6 papers) and Colorectal Cancer Screening and Detection (5 papers). The work is most often cited by research in Immunology (791 citations), Genetics (1.0k citations), Epidemiology (742 citations), Rheumatology (300 citations) and Hematology (201 citations). Fraser Cummings has collaborated with scholars based in United Kingdom, United States and Germany. Frequent co-authors include Simon Travis, Derek P. Jewell, Tariq Ahmad, Bryan F. Warren, N J McC Mortensen, Tilman Sánchez-Elsner, Alissa Walsh, Marijana Nedeljkovic Protic, John Beckly and Alessandra Geremia. Their work appears in journals such as Journal of Crohn s and Colitis, Inflammatory Bowel Diseases, Gut, Gastroenterology and Alimentary Pharmacology & Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact